Clinical Trials Browser

Phase 2 × High-Energy Shock Waves × Other hematologic neoplasm × Clear all

NCT01841723 2026-03-18

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

Phase 2 Active not recruiting

Other hematologic neoplasm

Leukemia, Hairy Cell